Navigation Links
VetStem Biopharma is Pleased to Share the Success Story of Rascal who was Treated with VetStem Cell Therapy by Dr. Deborah Fegan
Date:1/10/2019

Rascal was adopted from a local shelter when he was around two years old. According to his mom, Karen, he is a “Heinz 57 mixed breed.” Unfortunately, just six weeks after he was adopted, he tore his right cruciate ligament. Though he had his ACL surgically repaired, it is common for arthritis to form in the joint after such a traumatic injury.

Sure enough, when Rascal was about nine years old, he began showing symptoms of arthritis. According to his mom, he was walking stiffly and was having trouble jumping into their van. He was put on pain medication and underwent treatment with laser therapy however his owners could tell he was still in pain. X-rays revealed that he not only had arthritis in his right knee, but he also had early arthritis in his left knee and both hips as well. His veterinarian, Dr. Deborah Fegan of Big Creek Pet Hospital had recently become credentialed to perform VetStem Regenerative Cell Therapy and recommended that Rascal receive stem cell therapy. Rascal would be her first stem cell patient.

In March of 2018, Dr. Fegan collected fat from Rascal during a minimally invasive surgical procedure and shipped it to the VetStem laboratory in Poway, California. VetStem lab technicians processed the fat and extracted the stem cells to create injectable doses of Rascal’s own stem and regenerative cells. After quality checks were performed, the stem cell injections were shipped back to Dr. Fegan and within 48 hours of the initial fat collection, Rascal received one stem cell injection into his right knee and one injection intravenously. Stem cells, when given intravenously, have been demonstrated to migrate to areas of inflammation. For Rascal, his IV injection was for the radiographic changes seen in both hips and his left knee.

According to Karen, Rascal had a wonderful response to the stem cell therapy. She noticed steady improvement in the six months after his treatment. He began walking better and started jumping in the van again. Instead of sleeping most of the day as he had been doing he had, “a renewed interest in life.” He began to play with and challenge his newly adopted Lab brother. Karen stated, “They run around outside and have a great time. His brother Toby might be quicker, but Rascal is right there to have fun with him.” Overall, Karen could tell Rascal was feeling great and enjoying his life pain free. Pleased with Rascal’s outcome, Karen stated they would not hesitate to pursue stem cell therapy for their lab, should he need it in the future.

Now, nearly ten months after his stem cell treatment, Rascal continues to do well. According to his mom, he is still jumping into the van and going up and down steps easily. Karen stated, “His spirit has improved a lot. Though I wouldn't describe him as a youngster again, he certainly has recaptured some of his youthful movement and spirit. We continue to be very happy with the results we have seen from the stem cell treatment.”

Stem cells are regenerative cells that can differentiate into many tissue types, reduce pain and inflammation, help to restore range of motion, and stimulate regeneration of tendon, ligament and joint tissues. In a peer-reviewed study of dogs with chronic osteoarthritis of the hip joint, it was found that stem cells reduced lameness and pain.

About Deborah Fegan, DVM
Dr. Deborah Fegan has owned Big Creek Pet Hospital since 1992. She received her bachelor’s degree from West Virginia University followed by her DVM from Purdue University in 1979. She began practicing veterinary medicine in the Cleveland area in 1985. She has been VetStem Credentialed since 2017.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_biopharma_is_pleased_to_share_the_success_story_of_rascal_who_was_treated_with_vetstem_cell_therapy_by_dr_deborah_fegan/prweb16017159.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Veterinarian Dr. Patrick Leadbeater Brings VetStem Regenerative Cell Therapy to the Island of Kauai
2. VetStem Biopharma Shares News of the Successful Treatment of Partially Torn Cruciate Ligament in Young Labrador Retriever with the Pall V-PET™ Platelet Therapy System
3. VetStem Biopharma CEO, Dr. Robert Harman, will Present Data on Stem Cells for Kidney Disease in Poster Session at Feline Veterinary Conference
4. CEO of VetStem Biopharma, Dr. Robert Harman, to Present Results of Safety Study for Allogeneic Stem Cell Product at Regenerative Medicine Conference
5. New Patent for Adipose Stem Cells Issued to VetStem Biopharma
6. Dr. Bob Harman, CEO of VetStem Biopharma, Speaks on Stem Cells at Local Rotary Club
7. Dr. Bob Harman of VetStem Biopharma to Speak on the Business of Stem Cells at the Wild West Veterinary Conference
8. VetStem Biopharma CEO and Founder, Dr. Bob Harman, Interviewed in New Book "Stem Cell Therapy: A Rising Tide"
9. New Patent for Adipose Stem Cells Issued to VetStem
10. VetStem Biopharma Regenerative Cell Therapy has been Used on over 13,000 Animals
11. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, will present a clinical abstract on Allogeneic Adipose Stem Cell Bio-Distribution at the Veterinary Orthopedic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... , ... September 17, 2019 , ... Tucker, a Labrador ... only four months old, Tucker was limping and lame on his right hip and ... dysplasia and it was called “the worst case the vet had seen.” He was ...
(Date:9/17/2019)... ... September 16, 2019 , ... ... with the China Focus @ Biotech Week Boston, a forum organized by MyBioGate, ... in healthcare innovation. , After a careful process of evaluation, twelve companies out ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson ... focused on how best to characterize 3D cell culture models. The inherent problem of ... too thick and opaque to image through and therefore traditional wide-field or even confocal ...
(Date:8/29/2019)... ROCHESTER, N.Y. (PRWEB) , ... August 29, 2019 ... ... within a chronic disease affecting grapevines, a feat they hope will ultimately help ... products. , Researchers including several Rochester Institute of Technology faculty and alumni sequenced ...
Breaking Biology Technology:
(Date:8/27/2019)... ... August 26, 2019 , ... Shoreline Biome , ... strain level, has hired Bill McKenzie as its CEO and Karen Woodward as its ... Shoreline Biome meet growing demand for its products and expand the company’s sales worldwide. ...
(Date:8/27/2019)... ... August 27, 2019 , ... Ambry Genetics ... improve genetic testing guidelines. In the largest cohort study of its kind, Ambry ... at-risk patients. , Clinicians use guidelines to inform decisions about which patients ...
(Date:8/25/2019)... ... 2019 , ... Sierra Instruments is pleased to announce that their redesigned website ... live. Sierra has redesigned entry to the site with both engineers and those new ... to navigate with streamlined menus and simple access to resources and information on products ...
Breaking Biology News(10 mins):